You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

NIVL+IPIL

Cancer Type: Genitourinary, Renal cell / Kidney      Intent: Palliative
Regimen Category: Evidence-informed
Funding:
New Drug Funding Program
    Nivolumab plus Ipilimumab – Metastatic Renal Cell Carcinoma
New Drug Funding Program
    Nivolumab plus Ipilimumab – Metastatic Renal Cell Carcinoma

You might also be interested in